Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily

Colin S. Cunningham, Megan J. Moerke, Martin A. Javors, F. Ivy Carroll, Lance R. McMahon

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background and Purpose: Chronic treatment can differentially impact the effects of pharmacologically related drugs that differ in receptor selectivity and efficacy. Experimental Approach: The impact of daily nicotine treatment on the effects of nicotinic ACh receptor (nAChR) agonists was examined in two groups of rhesus monkeys discriminating nicotine (1.78 mg·kg−1base weight) from saline. One group received additional nicotine treatment post-session (1.78 mg·kg−1administered five times daily, each dose 2 h apart; i.e. Daily group), and the second group did not (Intermittent group). Key Results: Daily repeated nicotine treatment produced a time-related increase in saliva cotinine. There was no significant difference in the ED50values of the nicotine discriminative stimulus between the Daily and Intermittent group. Mecamylamine antagonized the effects of nicotine, whereas dihydro-β-erythroidine did not. Midazolam produced 0% nicotine-lever responding. The nAChR agonists epibatidine, RTI-36, cytisine and varenicline produced >96% nicotine-lever responding in the Intermittent group. The respective maximum effects in the Daily group were 100, 72, 59 and 28%, which shows that the ability of varenicline to produce nicotine-like responding was selectively decreased in the Daily as compared with the Intermittent group. When combined with nicotine, both varenicline and cytisine increased the potency of nicotine to produce discriminative stimulus effects. Conclusion and Implications: Nicotine treatment has a greater impact on the sensitivity to the effects of varenicline as compared with some other nAChR agonists. Collectively, these results strongly suggest that varenicline differs from nicotine in its selectivity for multiple nAChR subtypes.

Original languageEnglish (US)
Pages (from-to)3454-3466
Number of pages13
JournalBritish Journal of Pharmacology
Volume173
Issue number24
DOIs
StatePublished - 2016

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily'. Together they form a unique fingerprint.

Cite this